 |
|
A Comparative Study of Eight Fecal Occult Blood Tests and HemoQuant in Patients in Whom Colonoscopy Is Indicated
N. Gopalswamy, MD;
Herbert P. Stelling, MD;
Ronald J. Markert, PhD;
Henry N. Maimon, MD;
Sheri D. Wahlen, MD;
Richard I. Haddy, MD
Arch Fam Med. 1994;3(12):1043-1048.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Gabrielsson N, Granqvist S, Nilsson B. Guaiac tests for detection of occult faecal blood loss in patients with endoscopically verified colonic polyps. Scand J Gastroenterol. 1985;20:978-982.
PUBMED
2. Adlercreutz H, Liewendahl K, Virkola P. Evaluation of Fecatest, a new guaiac test for occult blood in feces. Clin Chem. 1978;24:756-761.
FREE FULL TEXT
3. Bertario L, Spinelli P, Gennari L, et al. Sensitivity of Hemoccult test for large bowel cancer in high-risk subjects. Dig Dis Sci. 1988;33:609-613.
PUBMED
4. Pye G, Jackson J, Thomas WM, Hardcastle JD. Comparison of Coloscreen selftest and HemoccultR faecal occult blood tests in the detection of colorectal cancer in symptomatic patients. Br J Surg. 1990;77:630-631.
PUBMED
5. Stelling HP, Maimon H, Smith RA, Bigley NJ, Mukherjee MD. New screening method for occult gastrointestinal bleeding: immunologic and guaiac slide tests. J Fam Pract. 1984;19:757-761.
PUBMED
6. Tate JJT, Northway J, Royle GT, Taylor I. Fecal occult blood testing in symptomatic patients: comparison of three tests. Br J Surg. 1990;77:523-526.
PUBMED
7. Adelcreutz H, Partanen P, Virkola P, Liewendahl K, Turunen MJ. Five guaiacbased tests for occult blood in faeces compared in vitro and in vivo. Scand J Clin Lab Invest. 1984;44:519-528.
PUBMED
8. Leicester RJ, Lightfoot A, Millar J, Colli-Jones DG. Accuracy and value of the Hemoccult test in symptomatic patients. BMJ. 1983;286:673-674.
FREE FULL TEXT
9. Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colorectal neoplasms: sensitivity, specificity, and predictive value: long-term follow-up in a large group practice setting. Ann Intern Med. 1990;112:328-333.
FREE FULL TEXT
10. Stelling HP, Maimon HN, Smith RA, Haddy RI, Markert RJ. A comparative study of fecal occult blood tests for early detection of gastrointestinal pathology. Arch Intern Med. 1990;150:1001-1005.
FREE FULL TEXT
11. Ahlquist DA, Klee GG, McGill DB, Ellefson RD. Colorectal cancer detection in the practice setting: impact of fecal blood testing. Arch Intern Med. 1990;150:1041-1045.
FREE FULL TEXT
12. St. John DJB, Young GP, Alexeyeff MA, et al. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology. 1993;104:1661-1668.
PUBMED
13. Barrows GH, Burton RM, Jarrett DD, Russell GG, Alford MD, Songster CL. Immunochemical detection of human blood in feces. Am J Clin Pathol. 1978;69:342-346.
PUBMED
14. Songster CL, Barrows GH, Jarrett DD. Immunochemical detection of fecal occult blood—the fecal smear punch-disk test: a new non-invasive screening test for colorectal cancer. Cancer. 1980;45:1099-1102.
PUBMED
15. Turunen MJ, Liewendahl K, Partanen P, Adelcreutz H. Immunological detection of fecal occult blood in colorectal cancer. Br J Cancer. 1984;49:141-148.
PUBMED
16. Saito H, Tsuchida S, Nakali S, et al. An immunochemical test for fecal occult blood by countercurrent immunoelectrophoresis. Cancer. 1985;56:1549-1552.
PUBMED
17. McDonald C, Buford Y, Walls R, Coulston K. Immunochemical testing for fecal occult blood in patients with colorectal cancer. Med J Australia. 1985;143:141-143.
PUBMED
18. Armitage N, Hardcastle JD, Amar SS, Haynes J, James PD. A comparison of an immuno-chemical faecal occult blood test Fecatwin sensitive/FECA-EIA with Haemoccult in population screening for colorectal cancer. Br J Cancer. 1985;51:799-804.
PUBMED
19. Ranshoff DF, Lang CA. Small adenomas detected during fecal occult blood test screening for colorectal cancer. JAMA. 1990;264:76-78.
FREE FULL TEXT
20. Herzog P, Holtermueller KH, Preiss J, et al. Fecal blood loss in patients with colonic polyps: comparison of measurements with 51chromium-labelled erythrocytes and with the Haemoccult test. Gastroenterology. 1982;83:957-962.
PUBMED
21. Heinrich HC, Icagic F. Comparative studies on the 'in vivo' sensitivity of four commercial pseudoperoxidase-based fecal occult blood tests in relation to actual blood losses as calculated from measured whole body 59Fe-elimination rates. Clin Wochenschr. 1980;58:1283-1297.
22. Leahy MBG, Pippard MJ, Salzmann MB, et al. Quantitative measurement of fecal blood loss: comparison of radioisotopic and chemical analysis. J Clin Pathol. 1991;44:391-394.
FREE FULL TEXT
23. Ahlquist DA, Wieand HS, Moertel CG, et al. Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and HemoQuant tests. JAMA. 1993;269:1262-1267.
FREE FULL TEXT
24. Neugut Al, Garbowski GC, Waye JD, et al. Diagnostic yield of colorectal neoplasia with colonoscopy for abdominal pain, change in bowel habits, and rectal bleeding. Am J Gastroenterol. 1993;88:1179-1183.
PUBMED
25. Young GP, St. John DJB. Selecting an occult blood test for use as a screening tool for large bowel cancer. In: Rozen P, Reich CB, Winawer SJ, eds. Frontiers in Gastrointestinal Research. Basel, Switzerland: Karger; 1991:135-156. 26. Thomas WM, Hardcastle JD. Role of upper gastrointestinal investigations in a screening study for colorectal neoplasia. Gut. 1990;31:1294-1297.
FREE FULL TEXT
27. Geller AJ, Kolts BE, Achem SR, Wears R. The high frequency of upper gastrointestinal pathology in patients with fecal occult blood and colon polyps. Am J Gastroenterol. 1993;88:1184-1187.
PUBMED
|
